Search

Treatment of acute lymphoblastic leukemia by activation of patient's immune cells by a bispecific antibody.

 

Abstract S722
Acute lymphoblastic leukemia  (ALL) is a rare type of blood cancer which is mainly treated by intensive chemotherapy.

Read more

Special airfare discount

A 10% discount on Air France or KLM airfares for EHA2025 attendees. If you'll be flying to EHA2025, you can benefit from a special discount courtesy of Air France-KLM Global Meetings & Events.

Read more

Chairs and Members

ChairJane Apperley

Co-chairAndreas Hochhaus

Executive Board members (2021–2027 term)
Prof Nicholas CP Cross, University of Southampton (UK)
Prof Oliver Hantschel, University of Marburg (Germany)
Dr Delphine Rea, University of Paris (France)
Dr Katerina Machova Polakova, Institute of Hematology and Blood Transfusion, Prague; Charles University (Czech Republic)
Prof…

Read more

EHA Kick-off Grant review and selection process

1. Eligibility checkAfter the deadline has passed, we'll check your application for completion and compliance with the eligibility criteria.

Read more

SWG Education Activities

Session at EHA2023The EHA2023 Congress was held in Frankfurt in June 2023. During the event, we held a session with the EHA Adolescent and Young Adult (AYA) Taskforce on the treatment of AYA patients with acute lymphoblastic leukaemia (ALL).

Read more